mRNA Cancer Vaccines Market Blog 4: Geriatric Oncology Surge — Why Older Adults Are the Fastest-Growing Patient Demographic for mRNA Therapies
While adults currently represent the largest patient demographic in the mRNA cancer vaccines market (projected to grow from $3.75 billion in 2024 to $23.4 billion by 2035), the geriatric population (age 65+) is emerging as the fastest-growing segment, driven by the global aging crisis and increasing cancer incidence in older adults. By 2035, adults over 65 will...
0 Comments 0 Shares 54 Views 0 Reviews